Acon Flowflex Sars-Cov-2 Antigen Rapid Test Kit

SARS-CoV-2 Rapid Antigen Test kit
Colloidal Gold Method Medical
Simple Rapid
Convenient
Sensitivity : 98.4%
Specificity : 98.1%
Test Time : 10-15min

Angiten-COVID-19 Virus Test Kit (Colloidal Gold)
Quantity of box: 25 persons/box
Brand: Easysweet
NMPA (National Medical Products Administration): Approved
CE: with CE mark
BfArM: listed
Test Method: Antigen Test
Result Time: 10-15 mins
Sample Type: Nasal Swab
Sensitivity: 96.70%
Specificity: 100%
Accuracy: 98.94%
Shelf Life: 24 months
Storage Temperature: 2-30 Degree Celsius
Country of Origin: Made in China
Additional Information:
Production Capacity: 1 million
Delivery Time: 10-15 days
Packaging Details: 25 tests in a pack, 40packs/ carton
Angiten-COVID-19 Virus Test Kit is an in vitro diagnostic rapid test for the qualitative detection of SARS-CoV-2 antigen (Ag) in human nasopharyngeal swab specimens from individuals who meet COVID-19clinical and / or epidemiological criteria. It can be used by professional only.

Price and Minumum Quantity
Price FOB in USD: NegotiableMinimum Order Qty: 10000
Production Capacity: 1000000Packaging: 25 Persons/box
Sample: Available. Sample Cost Born By Buyer
Product Model And Origin
Brand: Easysweet
HS Code: 3822009020
Standards: Ce
Competitive Advantages
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Best price with shortest delivery time
Other Details
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)
Angiten-covid-19 virus test kit (colloidal gold)

FlowFlex Sars-CoV-2 Antigen Rapid Test Self Test - Single Pack
The Flowflex SARS-CoV-2 Antigen Rapid Lateral FlowTest is a lateral flow chromatographic immunoassay for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasal swab specimens directly from individuals who are suspected of an active COVID-19 infection by their healthcare provider within the first seven days of the onset of symptoms.

Supplied in a single pack
Cassette Format
Detects the nucleocapsid protein antigen from SARS-CoV-2
Nasal Specimen sample. Anterior Nares Only Test (2-4cm inside the nostril)
Results in 15 minutes
CE Marked for Self Test
Used by NHS track and trace as home test
Unique ID QR code number on each cassette
Pack Contents

1 x Test Cassette with QR code and unique ID number
1 x Extraction Buffer Tube
1 x Disposable Swab
1 x Waste Bag
1 x Package Insert
Features:

Fully Home Use Approved
FDA Approved
Validation from Public Health England Porton Down.
Full Home Test Approval Granted in the UK & EU
Registered with MHRA and CE Marked.
Used and trusted by companies around the world including all UK airports and the NHS.

For in vitro qualitative detect of Covid-19 antigen in nasal(NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first 5 days of the onset of the symptoms. This test is only provided for use by clinical laboratories or to healthcare workers for point-of-care testing, and not for at home testing.

1.Easy to collect samples simple operation without professional equipment.
2.The test results are available in 15 minutes, and the test results are clearly visible. 3.Convenient transportation and low price, higher accuracy.
4.Suitable for large-scale rapid screening.

Shelf life: 24 Months
Test Result time: 10 Mins
Packing: 25 Pieces per Box

Covid-19 Self Test Kit

We are the authorized first vendor of ADTech!
KFDA CE approved,
FDA Pending
Price : Negotiable


Pre-Clinical Test Report
Accuracy
- In total samples 93.3% (14/15) - In positive samples 91.7% (11/12)

1. Pre-Clinical Test summary

1) Pre-clinical test is fulfilled by Domestic large clinical laboratory with ADTech COVID-19 IgM/IgG RAPID KIT
2) Tests are made by total 15 samples with 12 positive and 3 negative samples
3) Clinical Laboratory tested the sample with Immunofluorescence Analysis


2. Pre-clinical test result

1) Samples were tested by ADTech COVID-19 IgM/IgG RAPID KIT
2) Test result by ADTechs RAPID KIT
- 4 negatives and 11 positives results in 15 samples
3) Comparison between Immunofluorescence analysis and ADTechs RAPID KIT
- 14 test results are same(including negative and positive results) - 1 samples test result are different(Positive Negative by ADTech

Saliva Test Kit Painless testing plastic disposable Ag Rapid Detection Kit

Antibody Test Kits Hot Sale Medical Diagnostic Antigen Antibody Rapid Test Kits

1. Nasopharynx swab specimen, non-invasive
2. Very simple to use
3. Convenient, no devices required
4. Rapid, results within 20 minutes
5. Cost-efficient
6:Listed on German BfArm ,got approval by PEI
Clinical report from local CDC

Sensitivity is 97.14%, Specificity is 100%, total accuracy rate is 99.68%.

Sensitivity: 95.06% Specificity: 99.62%

Content of each kit: Test card (innovative and unique system), detailed instructions for use, sterile disposable swab, reactive solution for sample treatment, illustrative manual for use and operation.

General characteristics: CE self-diagnostic certification, holographic security label with individual code for authenticity verification, non-invasive, easy to use, no prescription required, rapid results in less than 15 minutes, high precision.

Sale restrictions: Exclusive sale to pharmacies, authorized companies, pharmaceutical distribution, socio-sanitary establishments, health establishments, occupational risk prevention, public organizations and health professionals.

Restricted sale to individuals. Sale subject to the provisions of Royal Decree 588/2021, of July 20, which modifies Royal Decree 1662/2000, of September 29, on medical devices for "in vitro" diagnosis, in order to regulate the sale to the public and the advertising of covid-19 self-diagnosis products. Sale subject in relation to tax matters to the provisions of Royal Legislative Decree 35/2020, of December 22, seventh final provision. Applicable tax rate of Value Added Tax to deliveries, imports and intra-community acquisitions of certain goods and provision of services necessary to combat the effects of SARS-CoV-2 as well as for the purposes of the special regime of the equivalence surcharge .